Feedback
European Shorting
My Portfolios
Browse Gurus
Print
Email
On July 11, 2012, CEO of InVitae Corporation of Genomic Health Inc. (GHDX) Randal W. Scott sold 30,000 shares at an average price of $35.39. The total transaction amount is $1,061,70.
In 2000, Randy founded Genomic Health and served as CEO until 2009 and executive chairman until 2012. He is currently director and has also taken the role of CEO of InVitae Corporation, a wholly owned subsidiary of the company, which was established in March this year.
On June 12, 2012, CEO of InVitae Corporation Randal W. Scott sold 30,000 shares of GHDX stock at the average price of $33.54. CFO Dean L. Schorno sold 4,000 shares of GHDX stock in May, March, April and February. In May, Director and 10% Owner Julian Baker bought 854,054 shares of GHDX stock.
Genomic Health reported their 2012 first quarter financial results. The company announced net income of $777,000 and total revenues of $58.5 million.
Subscribe RSS
RSS